Harfst & Associates’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-250
Closed -$36K 211
2017
Q2
$36K Hold
250
0.01% 148
2017
Q1
$34K Sell
250
-5,063
-95% -$682K 0.01% 163
2016
Q4
$673K Sell
5,313
-234
-4% -$29.9K 0.34% 21
2016
Q3
$737K Sell
5,547
-12
-0.2% -$1.62K 0.39% 19
2016
Q2
$725K Sell
5,559
-111
-2% -$14.2K 0.29% 64
2016
Q1
$699K Buy
5,670
+2
+0% +$243 0.45% 19
2015
Q4
$753K Sell
5,668
-50
-0.9% -$6.51K 0.31% 64
2015
Q3
$701K Buy
5,718
+1,069
+23% +$147K 0.31% 67
2015
Q2
$651K Buy
+4,649
New +$642K 0.37% 19

Other funds holding VHT

Harfst & Associates's VHT Position: Q3 2017 in Review

Harfst & Associates sold out of Vanguard Health Care ETF (VHT) in Q3 2017, closing a stake of 250 shares — an estimated $36K sold.

Harfst & Associates first reported a position in VHT in Q2 2015 and held it in 9 quarters. The position peaked at $753K in Q4 2015. 340 funds tracked by Wall St. Rank hold VHT as of Q3 2017.

  • Harfst & Associates reported no remaining Vanguard Health Care ETF position as of Q3 2017 after selling out during the quarter.
  • Harfst & Associates sold 250 Vanguard Health Care ETF shares in Q3 2017, an estimated $36K.
  • Harfst & Associates first reported a position in Vanguard Health Care ETF in Q2 2015 and held it in 9 quarters.
  • Harfst & Associates's Vanguard Health Care ETF position peaked at $753K in Q4 2015.
  • 340 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q3 2017.

Based on Harfst & Associates's 13F filing for Q3 2017, filed 7 Nov 2017.